Ongoing research has led to treatment advancements of malignant (cancerous) primary and metastatic brain tumors.
Join this webinar to:
• Learn about the latest treatment advancements of malignant (cancerous) primary & metastatic brain tumors in immunotherapy, radiation, and surgery
• Receive an overview of promising research and new treatment approaches on the horizon
• Understand the impact of treatments on the patient experience, such as cost, side effects, benefits, and risks
Dr. Erik Sulman of NYU Langone shares about the latest advancements in surgical approaches, radiation treatments, and immunotherapy..
-Video Contents-
00:00 Introduction
3:29 Primary Brain Tumors Overview
5:35 Classification of Brain Tumors & WHO Updates
10:24 Impact of New WHO System on Trials
16:56 How Clinical Trials are Designed
25:23 Ongoing Clinical Trials for Primary Brain Tumors
36:26 Immunotherapy for Primary Brain Tumors
40:00 Brain Metastases Overview
42:54 Studies with Radiation Therapy
47:52 Use of Immunotherapies and Targeted Therapies in Brain Metastases
50:57 New Technologies
54:22 Summary and Q&A
The ABTA educational webinars are designed for brain tumor patients and caregivers to learn more about brain tumor types, treatments and research. Webinars are 60 minutes and free to all who are interested. To learn about upcoming webinars, visit bit.ly/3xev6HE.
For more information or additional resources, contact the American Brain Tumor Association at (800) 886-2282, info@abta.org or visit www.abta.org/.